SCHEMBL3849352

SCHEMBL3849352

COC(=O)c1ccccc1-c1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2ccc3ncc(-c4ccc(OC)cc4)n3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
KMT2A Q03164 1/20 0.42
FYN P06241 3/20 0.39
TGFBR1 P36897 4/20 0.39
SLC6A3 Q01959 3/20 0.37
RIPK2 O43353 1/20 0.36
AKT1 P31749 1/20 0.36
AKT2 P31751 1/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA3 P34903 2/20 0.36
CLK1 P49759 1/20 0.36
DYRK1A Q13627 1/20 0.36
SLC6A4 P31645 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3850019 0.94 L3MBTL1 (0.41) L3MBTL1MEN1ALDH1A1KMT2AFYN
SCHEMBL3845403 0.91 TGFBR1 (0.40) L3MBTL1MEN1ALDH1A1KMT2AFYN
SCHEMBL3849271 0.87 TGFBR1 (0.39) L3MBTL1MEN1ALDH1A1KMT2ATGFBR1
SCHEMBL3846767 0.86 FYN (0.51) MEN1KMT2AFYNRIPK2AKT1
SCHEMBL3849706 0.85 FLT3 (0.46) L3MBTL1ALDH1A1FYNRIPK2AKT1
SCHEMBL3845039 0.81 TGFBR1 (0.46) ALDH1A1TGFBR1AKT1AKT2ATM
SCHEMBL3852197 0.80 TGFBR1 (0.40) L3MBTL1MEN1ALDH1A1KMT2ATGFBR1
SCHEMBL3854300 0.80 CLK1 (0.37) MEN1KMT2AFYNRIPK2CLK1
SCHEMBL3845857 0.78 CLK1 (0.48) L3MBTL1MEN1KMT2ACLK1DYRK1A
SCHEMBL3851642 0.77 TGFBR1 (0.45) TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed